NeoGenomics (NEO) Launches RaDaR ST to Capture Share in $20B MRD Market [Yahoo! Finance]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Yahoo! Finance
NeoGenomics Inc. (NASDAQ: NEO ) is one of the most buzzing stocks to buy with the highest upside potential . On February 25, NeoGenomics officially launched RaDaR ST, a tumor-informed circulating tumor DNA/ctDNA assay designed to detect molecular residual disease/MRD across various solid tumor types. This launch targets a rapidly growing MRD market estimated at over $20 billion, which NeoGenomics believes is currently less than 10% penetrated. By providing patient-specific molecular insights, the test allows clinicians to identify residual disease and recurrence earlier than traditional imaging, facilitating more timely treatment interventions. The RaDaR ST assay uses whole-exome sequencing and advanced bioinformatics to track up to 48 tumor-specific variants. It features a high level of sensitivity, with a limit of detection at 95% probability of 11 parts per million/ppm, ensuring the identification of trace amounts of tumor DNA. The test has been validated through clinical and re
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know [Yahoo! Finance]Yahoo! Finance
- NeoGenomics (NEO) had its "buy" rating reaffirmed by TD Cowen.MarketBeat
- NeoGenomics (NEO) had its "market perform" rating reaffirmed by William Blair.MarketBeat
- NeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling [Yahoo! Finance]Yahoo! Finance
- NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy ProfilingBusiness Wire
NEO
Earnings
- 2/17/26 - Beat
NEO
Sec Filings
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- NEO's page on the SEC website